Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

Breast Cancer Screening Decision Aid: A Survey-based Comparison of Video and Written Formats

NCT ID: NCT07515846Sponsor: Yale UniversityLast updated: 2026-05-04

Summary

This is a randomized survey study of 2 decision aids for breast cancer screening. Decision aids are tools that present structured information to patients about a medical test or treatment. The goal of this study is to compare a video-based decision aid to a written decision aid and assess the impact on intention to screen in the future, readiness to make a decision about screening, and knowledge of screening. The study will use an online survey platform (YouGov) and will include women 75 and older who have been previously screened for breast cancer and do not have a history of breast cancer.

Arms & interventions

  • BehavioralVideo based decision aid

    A \<4 minute video that describes the screening decision, risks, and benefits of screening

  • BehavioralWritten decision aid

    An electronic document that describes the screening decision, risks and benefits of screening

Outcome measures

Primary

  • Mean Decisional Conflict Scale (DCS) score

    DCS is a 16-item scale measuring uncertainty in health choices, covering informedness, values, support, uncertainty, and effective decision-making. Total scores range from 0 (no conflict) to 100 (high conflict).

    Time frame: Baseline and Immediately post intervention, about 20 minutes

Secondary

  • Mean Screening Intention score

    Time frame: Baseline and Immediately post intervention, about 20 minutes

  • Percent correct knowledge of breast cancer screening score

    Time frame: Baseline and Immediately post intervention, about 20 minutes

  • Understanding of overdiagnosis

    Time frame: Baseline and Immediately post intervention, about 20 minutes

Eligibility criteria

Sex: FemaleAge: 75 Years and olderHealthy volunteers: Yes
Inclusion Criteria: * No prior history of breast cancer or ductal carcinoma in situ * Screened at least once before * English-speaking * Able to complete an online survey * Did not opt out of participation Exclusion Criteria: * Prior history of breast cancer or ductal carcinoma in situ

Study locations (1)

Yale School of Medicine

New Haven, Connecticut, 06511

Recruiting
Ilana Richman, MD · Contact